GTR 104968924
Tenders Are Invited For Antineoplastic And Immunomodulating Agents - Supply Of Oncological Medicines In The National Oncology Program
ICB — International Competitive Bid
Closed
Eastern Europe
Tender Information
GTR Reference
104968924
Tendering Authority
Subscribe to view
Tender No
763365-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Antineoplastic And Immunomodulating Agents - Supply Of Oncological Medicines In The National Oncology Program
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
Balkans,European Union
Last Date of Bid Submission
22-12-2025
Closed
Work Detail
Antineoplastic And Immunomodulating Agents - Supply Of Oncological Medicines In The National Oncology Program. Zoledronic Acid Conc. Pt. The Sun Perf.,Zoledronic Acid Sol Perf,Atezolizumab 1200Mg,Avelumabum 200Mg,Bevacizumab (Avastin) 100Mg,Bevacizumab (Mvasi) 100Mg,Bevacizumab (Oyavas) 100Mg,Bevacizumab (Avastin) 400Mg,Bevacizumab (Mvasi) 400Mg,Bevacizumab (Oyavas) 400Mg,Bleomycinum Sulfas 15000Ui,Cabazitaxelum 60Mg,Calcii Folinas 100 Mg,Calcii Folinas 200 Mg,Calcii Folinas 350 Mg,Carboplatinum 50Mg,Carboplatinum 150 Mg,Carboplatinum 450Mg,Carboplatinum 600Mg,Cemiplimab 350Mg,Cetuximabum 100Mg,Cisplatinum 50 Mg,Cisplatinum 100 Mg,Cyclophosphamidum 1000 Mg,Cyclophosphamidum 500 Mg,Dacarbazinum 200Mg,Docetaxelum 80 Mg,Docetaxelum 20 Mg,Docetaxelum 160 Mg,Doxorubicin 50 Mg,Doxorubicin 100 Mg,Doxorubicin 200 Mg,Doxorubicinum (Caelyx) 20Mg,Doxorubicinum (Myocet) 50 Mg,Durvalumabum 120 Mg,Durvalumabum 500 Mg,Epirubicine 20 Mg,Epirubicine 50 Mg,Epirubicin 100 Mg,Eribulin 0.88Mg,Etoposidum 100 Mg,Etoposidum 200 Mg,Fluorouracilum 1000 Mg,Fluorouracilum 2500 Mg,Fluorouracilum 5000 Mg,Gemcitabinum Conc Pt Sol Perf 1000 Mg,Gemcitabinum Conc Pt Sol Perf. 2000 Mg,Gemcitabinum Pulb. Pt. Sol. Perf 1000 Mg,Gemcitabine Powder Pt. The Sun Perf 2000Mg,Ipilimumabum 50 Mg,Recommended 200 Mg,Irinotecanum 40 Mg,Irinotecanum 100 Mg,Irinotecanum 300 Mg,Irinotecanum 500 Mg,Irinotecanum (Onivyde) 43Mg,Methotrexatum 5000Mg,Mitoxantronum 20Mg,Nivolumabum 40 Mg,Nivolumabum 100 Mg,Nivolumabum 120 Mg,Oxaliplatinum 50 Mg,Oxaliplatinum 100 Mg,Oxaliplatinum 200 Mg,Paclitaxelum 100 Mg,Paclitaxelum 150 Mg,Paclitaxelum 300 Mg,Panitumumabum 100 Mg,Panitumumabum 400 Mg,Pembrolizumabum 100 Mg,Pemetrexedum Conc Pt Sol Perf.100 Mg,Pemetrexedum Conc Pt Sol Perf 500 Mg,Pemetrexedum Conc Pt Sol Perf.1000 Mg,Pemetrexedum Pulb. Pt. Conc. Pt. Sol. Perf. 100 Mg,Pemetrexedum Pulb. Pt. Conc. Pt. Sol. Perf. 500 Mg,Pemetrexedum Pulb. Pt. Conc. Pt. Sol. Perf. 1000 Mg,Pertuzumabum 420 Mg,Ramucirumabum 100 Mg,Topotecanum 1 Mg,Topotecanum Conc. Pt. Sol. Perf. 4Mg,Topotecanum Pulb. Pt. Conc. Pt. Soil. Perf. 4 Mg,Trabectedin Pulb. Pt. Conc. Pt. The Sun Perf. 0.25 Mg,Trabectedin Pulb. Pt. Conc. Pt. The Sun Perf. 1 Mg,Trastuzumab (Trazimera) Powder. Pt. Conc. Pt. Soil. Perf. 150 Mg,Trastuzumab (Trazimera) Powder. Pt. Conc. Pt. Soil. Perf. 420 Mg,Trastuzumab (Zercepac) Powder. Pt. Conc. Pt. Soil. Perf. 60 Mg,Trastuzumab (Zercepac) Powder. Pt. Conc. Pt. Soil. Perf. 150 Mg,Trastuzumab (Herceptin) Powder. Pt. Conc. Pt. Soil. Perf. 150Mg,Trastuzumab (Herzuma) Powder. Pt. Conc. Pt. Soil. Perf. 150 Mg,Trastuzumab (Ogivri) Pulb. Pt. Conc. Pt. Sol. Perf. 150Mg,Trastuzumab (Kanjinti) Powder. Pt. Conc. Pt. Soil. Perf. 150Mg,Trastuzumab (Kanjinti) Pulb. Pt. Conc. Pt. Sol. Perf. 420Mg,Trastuzumab Emtansinum Pulb. Pt. Conc. Pt. Sol. Perf. 100Mg,Trastuzumab Emtansinum Pulb. Pt. Conc. Pt. Sol. Perf. 160Mg,Trastuzumab Deruxtecan Pulb Pt. Conc. Pt. The Sun Perf. 100 Mg,Vincristinum Pulb. Pt. Soil. Eng./Perf. Iv 1Mg,Vinorelbinum Conc. Pt. Sol. Perf. 10Mg,Vinorelbinum Conc. Pt. The Sun Perf. 50 Mg
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
5ab9688b-a9c6-4599-8c53-dbe87f53ff81.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.